Scinai Immunotherapeutics... (SCNI)
NASDAQ: SCNI
· Real-Time Price · USD
1.57
-0.02 (-1.26%)
At close: Aug 18, 2025, 3:59 PM
1.60
1.81%
After-hours: Aug 18, 2025, 07:02 PM EDT
-1.26% (1D)
| Bid | 1.56 |
| Market Cap | 1.27M |
| Revenue (ttm) | 1.24M |
| Net Income (ttm) | 4.35M |
| EPS (ttm) | 2.4 |
| PE Ratio (ttm) | 0.65 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.6 |
| Volume | 77,429 |
| Avg. Volume (20D) | 1,407,590 |
| Open | 1.63 |
| Previous Close | 1.59 |
| Day's Range | 1.56 - 1.65 |
| 52-Week Range | 1.40 - 6.18 |
| Beta | 1.86 |
About SCNI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SCNI
Website n/a
2 months ago
+28.97%
Scinai Immunotherapeutics shares are trading highe...
Unlock content with
Pro Subscription
5 months ago
+3.89%
Scinai shares are trading higher after the company signed a $10 million standby equity agreement and retained control over stock sales to Yorkville.
12 months ago · seekingalpha.com
Scinai Immunotherapeutics Ltd. (SCNI) Q2 2024 Earnings Call TranscriptScinai Immunotherapeutics Ltd. (NASDAQ:SCNI ) Q2 2024 Results Conference Call August 20, 2024 11:00 AM ET Company Participants Liat Halpert - Head of Business Development Amir Reichman - CEO Liat Halp...
